Terbutaline sulfate 2.5 MG Oral Tablet — RxCUI 857677
RxNorm drug concept · Semantic clinical drug
RxCUI 857677
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI857677
Official nameTerbutaline sulfate 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped26
Reported Medicaid activity (SDUD)110 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Terbutaline Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It helps open tight airways. It is used to prevent and reverse bronchospasm in people 12 and older with asthma, or with bronchitis and emphysema.
- It is injected under the skin, usually in the upper arm. You may notice a change in airflow within about 5 minutes, with a clear improvement by about 15 minutes. The effect usually...
- How is it given and how fast does it work?
- Shakiness, nervousness, a pounding heartbeat, headache, dizziness and drowsiness are common. They are usually brief. Call for help if you have chest pain, a very fast or irregular...
🕸️ Concept Web — How Terbutaline sulfate 2.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Terbutaline sulfate 2.5 MG Oral Tablet
RxCUI 857677 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Terbutaline
10368IN -
Terbutaline sulfate
10369PIN
-
Terbutaline
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Terbutaline Oral Tablet
374040SCDF -
Terbutaline sulfate Oral Tablet
2647778SCDFP -
Terbutaline Oral Product
1164239SCDG -
Terbutaline Pill
1164240SCDG -
Terbutaline sulfate Oral Product
2663584SCDGP -
Terbutaline sulfate Pill
2662164SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Terbutaline Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Terbutaline sulfate 2.5 MG
857676SCDC
-
Terbutaline sulfate 2.5 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Terbutaline sulfate 2.5 MG
SCDC · 857676 -
Terbutaline Oral Tablet
SCDF · 374040 -
Terbutaline sulfate Oral Tablet
SCDFP · 2647778 -
Terbutaline Oral Product
SCDG · 1164239 -
Terbutaline Pill
SCDG · 1164240 -
Terbutaline sulfate Oral Product
SCDGP · 2663584 -
Terbutaline sulfate Pill
SCDGP · 2662164
📦 FDA Products & Package NDCs
12 products · 26 package NDCs
26 package NDCs map to RxCUI 857677 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00115-2611-01 | 100 TABLET in 1 BOTTLE (0115-2611-01) | TERBUTALINE SULFATE | Amneal Pharmaceuticals of New York LLC | 2001-06-26 |
| 00115-2611-02 | 500 TABLET in 1 BOTTLE (0115-2611-02) | TERBUTALINE SULFATE | Amneal Pharmaceuticals of New York LLC | 2001-06-26 |
| 00115-2622-01 | 100 TABLET in 1 BOTTLE (0115-2622-01) | TERBUTALINE SULFATE | Amneal Pharmaceuticals of New York LLC | 2001-06-26 |
| 00115-2622-02 | 500 TABLET in 1 BOTTLE (0115-2622-02) | TERBUTALINE SULFATE | Amneal Pharmaceuticals of New York LLC | 2001-06-26 |
| 00527-1311-01 | 100 TABLET in 1 BOTTLE (0527-1311-01) | Terbutaline Sulfate | Lannett Company, Inc. | 2005-03-25 |
| 00527-1311-10 | 1000 TABLET in 1 BOTTLE (0527-1311-10) | Terbutaline Sulfate | Lannett Company, Inc. | 2005-03-25 |
| 00527-1318-01 | 100 TABLET in 1 BOTTLE (0527-1318-01) | Terbutaline Sulfate | Lannett Company, Inc. | 2005-03-25 |
| 00527-1318-10 | 1000 TABLET in 1 BOTTLE (0527-1318-10) | Terbutaline Sulfate | Lannett Company, Inc. | 2005-03-25 |
| 24979-0132-01 | 100 TABLET in 1 BOTTLE (24979-132-01) | Terbutaline Sulfate | Upsher-Smith Laboratories, LLC | 2020-07-13 |
| 24979-0132-03 | 1000 TABLET in 1 BOTTLE (24979-132-03) | Terbutaline Sulfate | Upsher-Smith Laboratories, LLC | 2020-07-13 |
| 24979-0133-01 | 100 TABLET in 1 BOTTLE (24979-133-01) | Terbutaline Sulfate | Upsher-Smith Laboratories, LLC | 2020-07-13 |
| 24979-0133-03 | 1000 TABLET in 1 BOTTLE (24979-133-03) | Terbutaline Sulfate | Upsher-Smith Laboratories, LLC | 2020-07-13 |
| 62135-0524-90 | 90 TABLET in 1 BOTTLE (62135-524-90) | Terbutaline Sulfate | Chartwell RX, LLC. | 2023-02-28 |
| 62135-0525-90 | 90 TABLET in 1 BOTTLE (62135-525-90) | Terbutaline Sulfate | Chartwell RX, LLC. | 2023-02-28 |
| 62559-0721-01 | 100 TABLET in 1 BOTTLE (62559-721-01) | Terbutaline Sulfate | ANI Pharmaceuticals, Inc. | 2018-10-16 |
| 62559-0722-01 | 100 TABLET in 1 BOTTLE (62559-722-01) | Terbutaline Sulfate | ANI Pharmaceuticals, Inc. | 2018-10-16 |
| 71205-0938-00 | 100 TABLET in 1 BOTTLE (71205-938-00) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0938-30 | 30 TABLET in 1 BOTTLE (71205-938-30) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0938-55 | 500 TABLET in 1 BOTTLE (71205-938-55) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0938-60 | 60 TABLET in 1 BOTTLE (71205-938-60) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0938-90 | 90 TABLET in 1 BOTTLE (71205-938-90) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0939-00 | 100 TABLET in 1 BOTTLE (71205-939-00) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0939-30 | 30 TABLET in 1 BOTTLE (71205-939-30) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0939-55 | 500 TABLET in 1 BOTTLE (71205-939-55) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0939-60 | 60 TABLET in 1 BOTTLE (71205-939-60) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
| 71205-0939-90 | 90 TABLET in 1 BOTTLE (71205-939-90) | Terbutaline Sulfate | Proficient Rx LP | 2020-11-19 |
Observed labelers:
Proficient Rx LP (10) ·
Amneal Pharmaceuticals of New York LLC (4) ·
Lannett Company, Inc. (4) ·
Upsher-Smith Laboratories, LLC (4) ·
ANI Pharmaceuticals, Inc. (2) ·
Chartwell RX, LLC. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.